Credit Suisse Ag Prothena Corp Public LTD CO Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Credit Suisse Ag holds 60,202 shares of PRTA stock, worth $900,019. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,202

Previous 59,304 1.51%

Holding current value

$900,019

Previous $2.16 Million 30.81%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$24.75 - $40.66 $22,225 - $36,512	898 Added 1.51%	60,202 $1.49 Million
Q4 2023 Feb 08, 2024	BUY	$32.31 - $52.32 $244,037 - $395,172	7,553 Added 14.59%	59,304 $2.16 Million
Q3 2023 Nov 13, 2023	SELL	$47.3 - $70.6 $267,055 - $398,607	-5,646 Reduced 9.84%	51,751 $2.5 Million
Q2 2023 Aug 11, 2023	BUY	$48.26 - $78.59 $756,813 - $1.23 Million	15,682 Added 37.59%	57,397 $3.92 Million
Q1 2023 May 10, 2023	BUY	$46.97 - $58.27 $132,831 - $164,787	2,828 Added 7.27%	41,715 $2.02 Million
Q4 2022 Feb 13, 2023	BUY	$52.05 - $65.0 $396,048 - $494,585	7,609 Added 24.33%	38,887 $2.34 Million
Q3 2022 Nov 10, 2022	BUY	$25.16 - $60.63 $89,418 - $215,479	3,554 Added 12.82%	31,278 $1.9 Million
Q2 2022 Aug 12, 2022	BUY	$22.73 - $39.98 $8,387 - $14,752	369 Added 1.35%	27,724 $753,000
Q1 2022 May 16, 2022	BUY	$30.27 - $49.22 $114,511 - $186,199	3,783 Added 16.05%	27,355 $1 Million
Q4 2021 Feb 14, 2022	SELL	$42.11 - $73.26 $69,902 - $121,611	-1,660 Reduced 6.58%	23,572 $1.17 Million
Q3 2021 Nov 12, 2021	BUY	$48.2 - $78.89 $135,104 - $221,128	2,803 Added 12.5%	25,232 $1.8 Million
Q2 2021 Aug 16, 2021	BUY	$21.63 - $57.65 $64,327 - $171,451	2,974 Added 15.29%	22,429 $1.15 Million
Q1 2021 May 14, 2021	SELL	$11.0 - $28.24 $180,708 - $463,926	-16,428 Reduced 45.78%	19,455 $488,000
Q4 2020 Feb 12, 2021	SELL	$10.12 - $13.94 $97,789 - $134,702	-9,663 Reduced 21.22%	35,883 $430,000
Q3 2020 Nov 13, 2020	SELL	$9.93 - $13.47 $74,246 - $100,715	-7,477 Reduced 14.1%	45,546 $455,000
Q2 2020 Aug 12, 2020	BUY	$9.56 - $12.51 $251,925 - $329,663	26,352 Added 98.8%	53,023 $555,000
Q1 2020 May 13, 2020	SELL	$7.54 - $15.77 $5,715 - $11,953	-758 Reduced 2.76%	26,671 $285,000
Q4 2019 Feb 12, 2020	SELL	$7.48 - $17.01 $11,466 - $26,076	-1,533 Reduced 5.29%	27,429 $434,000
Q3 2019 Nov 12, 2019	BUY	$6.89 - $10.45 $22,537 - $34,181	3,271 Added 12.73%	28,962 $227,000
Q2 2019 Aug 14, 2019	SELL	$8.85 - $12.49 $6,318 - $8,917	-714 Reduced 2.7%	25,691 $271,000
Q1 2019 May 14, 2019	SELL	$10.32 - $14.49 $90,176 - $126,613	-8,738 Reduced 24.86%	26,405 $321,000
Q4 2018 Feb 13, 2019	BUY	$8.73 - $13.74 $42,357 - $66,666	4,852 Added 16.02%	35,143 $362,000
Q3 2018 Nov 13, 2018	SELL	$12.7 - $15.79 $133,184 - $165,589	-10,487 Reduced 25.72%	30,291 $396,000
Q2 2018 Aug 14, 2018	SELL	$10.99 - $44.21 $117,318 - $471,941	-10,675 Reduced 20.75%	40,778 $595,000
Q1 2018 May 15, 2018	BUY	$27.95 - $45.04 $66,157 - $106,609	2,367 Added 4.82%	51,453 $1.89 Million
Q4 2017 Feb 14, 2018	SELL	$35.44 - $63.76 $3.35 Million - $6.03 Million	-94,526 Reduced 65.82%	49,086 $1.84 Million
Q3 2017 Nov 14, 2017	BUY	$53.83 - $67.75 $1.01 Million - $1.27 Million	18,703 Added 14.97%	143,612 $9.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	124,909	124,909 $6.76 Million

Others Institutions Holding PRTA

# of Institutions

198

Shares Held

44.5M

Call Options Held

601K

Put Options Held

259K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $701M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account